Related Experiment Video
Updated: May 8, 2026
08:30
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
On the versatility of von Willebrand factor
Antoine Rauch1, Nikolett Wohner, Olivier D Christophe
1INSERM Unit 770, Le Kremlin-Bicêtre, France. ; UMR_S 770, Univ Paris-Sud, Le Kremlin-Bicêtre, France. ; Department of Hematology & Transfusion, Lille University Hospital, Lille, France. ; Equipe d'Accueil 2693, Lille-II University, Lille, France.
Mediterranean Journal of Hematology and Infectious Diseases
|August 13, 2013
Summary
Von Willebrand factor (VWF) is crucial for blood clotting and its abnormalities cause bleeding disorders. VWF also plays roles in non-hemostatic processes, impacting thrombosis and other diseases.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Von Willebrand factor (VWF) is a key protein in hemostasis.
- VWF abnormalities lead to Von Willebrand disease (VWD) and thrombotic risks.
- Understanding VWF structure-function is vital for hemostasis and disease.
Purpose of the Study:
- To review VWF structure-function relationships.
- To explore VWF's role in hemostasis and non-hemostatic processes.
- To provide insights into VWF's versatile functions.
Main Methods:
- Literature review of VWF studies.
- Analysis of VWF structure-function relationships.
- Investigation of VWF interactions with ligands (e.g., Factor VIII, collagen).
Main Results:
- VWF's pivotal role in the haemostatic system confirmed.
- Identified interactive sites for VWF ligands and confirmed their physiological relevance.
- Revealed VWF's involvement in non-hemostatic processes like intimal thickening and inflammation.
Conclusions:
- VWF structure dictates its function in hemostasis.
- VWF has broader roles beyond blood clotting.
- Further research into VWF's non-hemostatic functions is warranted.
Related Concept Videos
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:10Blood Typing
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
01:06Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...